CVS announced it will add 12 states to its program to sell the opioid overdose antidote naloxone without a prescription, bringing the total to 14. The company already sells naloxone without a prescription in Massachusetts and Rhode Island.
Many primary care physicians have misconceptions about opioid abuse, a new survey finds. Almost half of internists, family physicians and general practitioners incorrectly believe that abuse-deterrent pills are less addictive than standard opioid painkillers, according to the survey.
CVS Health Corp has agreed to pay $22 million to resolve a federal investigation into whether two of its pharmacies in Florida sold oxycodone pills that were not prescribed for legitimate medical purposes, Reuters reports.
Doctors and nurses should undergo random drug testing, argues a leading medical ethicist. “I am sorry to say that addiction and the abuse of drugs are not really a part of the discussion about making medicine safer,” says Arthur L. Caplan, PhD.
A survey of primary care doctors nationwide finds almost half say they are less likely to prescribe narcotic painkillers compared with a year ago. Ninety percent of those surveyed say they are concerned about prescription drug abuse in their communities.
Walgreen and Rite Aid are unlikely to follow the lead of CVS in halting tobacco sales, experts say. Unlike CVS, which reported revenue growth in the third quarter of this year, its rivals do not have pharmacy benefit management units.